What You Should Know
- The Partnerships: Enterprise AI platform Abridge has secured multi-year content partnerships with the NEJM Group (publisher of the New England Journal of Medicine) and the American Medical Association (publisher of the JAMA Network).
- The Workflow Shift: The integration allows clinicians to ask complex clinical questions and receive evidence-based answers directly within their existing workflow. Historically, finding this literature required breaking focus, leaving the EHR, and searching external databases.
- The Context Engine: The Abridge Clinical Decision Support (CDS) system will now surface insights that are grounded in both elite peer-reviewed research and the specific patient context captured during the ambient listening phase of the encounter.
Context-Aware Insights in Real Time
Historically, clinicians seeking reliable research during an encounter had to step away from the patient, open separate tools, and perform manual searches. The Abridge platform solves this “workflow friction” by integrating content from the New England Journal of Medicine, JAMA, and 11 specialty journals directly into its AI-powered system.
This integration supports the “full arc” of the clinical encounter:
- Pre-visit Preparation: Helping clinicians review relevant data before entering the room.
- During the Conversation: Capturing the patient interaction and surfacing cited insights to clinical questions in real time.
- Post-visit Documentation: Generating structured notes and grounding them in peer-reviewed evidence and patient context.
“Clinicians are managing more complexity than ever,” said Dr. Shiv Rao, CEO and Co-Founder of Abridge. “We are committed to ensuring that [scientific] standard is integrated into the clinical encounter as contextual insight grounded in the patient conversation.”
Grounding AI in Trusted Evidence
As AI increasingly shapes clinical decision-making, the necessity for “grounded” information—data backed by peer-reviewed science rather than just statistical probability—has become paramount.
“Our role is to ensure [AI] is grounded in trusted, peer-reviewed evidence,” noted David Sampson, Vice President and Chief Publishing Officer at NEJM Group. By delivering this evidence into the course of care, Abridge aims to inform physician-patient judgment with the highest scientific standards available.
Availability and Expansion
Abridge is currently projected to support over 100 million patient-clinician conversations this year across 250 of the largest health systems in the U.S.
- Current Availability: Abridge’s clinical decision support is already live with context-aware insights from Wolters Kluwer’s UpToDate.
- Upcoming Integrations: Content from the NEJM Group and JAMA Network is expected to become generally available within the platform in the coming months.
